NR3C2 and Insulin resistance: Inhibition of MRs or adrenalectomy improves insulin resistance in patients with primary aldosteronism (Catena et al. 2006) and MR antagonists have been shown to improve coronary endothelial function in diabetic patients (Garg et al. 2015).